The PCa diagnosis is confirmed by histopathological analysis of prostate biopsy cores, after a suspiciously elevated prostate-specific antigen (PSA) or positive digital rectal examination (DRE). This evidence concerns the gene KLK3 and posterior cortical atrophy.